ロード中...
A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials
Historically, phase II oncology trials assessed a treatment’s efficacy by examining its tumor response rate in a single-arm trial. Then, approximately 25 years ago, certain statistical and pharmacological considerations ignited a debate around whether randomized designs should be used instead. Here,...
保存先:
| 出版年: | J Natl Cancer Inst |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6910171/ https://ncbi.nlm.nih.gov/pubmed/31218346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz126 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|